Robotics approved for use in NHS surgeries across England
State-of-the-art robotic systems approved for use on the NHS could transform treatment for thousands of people across England.
The technology, given the green light by the National Institute for Health and Care Excellence (Nice) under its early value assessment programme, offers a range of applications, from helping remove tumours to replacing a patient's knee.
The rollout is expected to reduce hospital stays, faster recovery times, and a lower risk of complications.
A total of 11 systems have been approved, including five for soft tissue surgeries, such as removing tumours, repairing hernias and removing gallbladders and six for orthopaedics, including knee and hip replacements.
Some allow surgeons to perform operations using mechanical arms controlled from a console, while others are hand-held.
Dr Anastasia Chalkidou, programme director of Nice's HealthTech programme, said: 'These innovative technologies have the potential to transform both soft tissue and orthopaedic surgical care in the NHS.
'Robot-assisted surgery may help overcome key limitations of conventional techniques through precise movements and enhanced 3D visualisation, potentially transforming surgical options and outcomes for NHS patients.
'Both applications could benefit patients who might not otherwise be candidates for minimally invasive approaches.'
Under the guidance, the 11 systems can be used over the coming three years while more evidence is collected.
Among the issues Nice will look at are how the technology affects the length of hospital stays and waiting lists, as well as the resources used for training staff and the costs of implementing the systems.
Each of the systems costs between £500,000 and £1.5 million, according to the NHS spending watchdog, and are usually deployed in specialist centres where hundreds of operations take place each year.
Dr Chalkidou added: 'The data gathered over the next three years will allow us to evaluate exactly how these technologies can improve patient care and help ensure NHS resources are directed toward interventions that deliver meaningful clinical benefits and long-term value to our health service.'
In 2011-12, the majority of robot-assisted procedures were for urological cancer, which can include cancer in the bladder, kidney, prostate and testicles, according to Nice.
By last year, almost half of these operations were for other conditions, with a surge in the use of robotic surgeries for bowel cancer, which now accounts for a quarter of all robot-assisted procedures.
There has also been a jump in the use of the technology in orthopaedics, with 4,000 robot-assisted surgeries taking place last year, up from 300 in 2018-19.
Making greater use of digital technologies in the NHS is one of the three shifts set to be outlined by the Government in its forthcoming 10-year health plan.
It is also expected to focus more on sickness prevention and moving care from hospitals into the community.
Professor Sir Stephen Powis, national medical director at NHS England, said: 'This is fantastic news for patients and shows that the NHS continues to find new ways to utilise the latest technological innovations to improve care.
'This will be a vital element of the 10-year health plan which will be published in the coming months.
'Robot-assisted surgery is crucial to the future of high-quality healthcare – and with benefits including shorter stays in hospital, faster recovery for patients and less invasive procedures, these advancements will have a knock-on effect throughout the system and help patients get treated quicker.
'This is an important step forward as we continue to work to ensure everyone is able to get high-quality care when they need it.'
Nuha Yassin, a consultant colorectal surgeon and Royal College of Surgeons of England council member, described the Nice guidance as a 'significant step forward'.
'The potential for faster recovery times, reduced complications and increased access to minimally invasive procedures could transform patient care,' she said.
'It remains important that, in introducing these new technologies, NHS trusts and surgical teams ensure they are working within the guidelines set out by the Royal College of Surgeons of England, so that they are implemented in the safest way possible for patients.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
13 minutes ago
- South Wales Argus
UK Mounjaro warning issued ahead of heatwave temperatures
It's estimated that around 1.5 million Brits are now taking weight-loss drugs, with numbers increasing each week. The last year has seen a huge increase in the number of people taking GLP-1 receptor agonists, some prescribed by the NHS and others by private doctors, with common injectibles including semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro) and liraglutide (Saxenda). As the temperatures rise, experts are stressing that users must store weight loss injections in a refrigerator (2-8°C or 36-46°F), especially after starting the course. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 'Weight loss injections can be adversely affected by hot weather, particularly regarding storage and stability," says James O'Loan, obesity specialist and weight loss injection expert at pharmacists Chemist4U. "Understanding the storage instructions when using any prescribed medication is vital to keep it in optimal condition. "Although weight loss injections can be stored at room temperature for up to 30 days (some injections are 42 days, so always check with your prescriber or refer to the patient information leaflet), this is only provided the temperature does not exceed 30°C. During hot weather, and to be on the safe side, it is always best to keep your weight loss injections refrigerated if you're able." Can I take my Mounjaro pen on holiday? The advice for the UK heatwave is also also worth noting for those heading on holiday or travelling during the warmer weather. However, if you're flying, remember to pack your injections in your carry-on since the baggage hold on a plane can plummet to below-freezing temperatures. Finding the right temperature for your pen is important: not too hot or too cold. If you inject after incorrectly storing your pen, it might not be safe for use. How do I know if my Mounjaro pen is safe to use? "There are a few important things to consider when checking if your weight loss pen is safe to use," says James. "Inspect the pen to ensure it is not damaged and the medicine inside is clear, with no particles or cloudiness. The liquid should be colourless or slightly yellow. If you have left your pen unrefrigerated during hot weather and are unsure whether it is still safe to use, always consult your prescriber before injecting. "Staying hydrated whilst taking weight loss injections is key. Weight loss injections can cause side effects such as nausea, constipation, diarrhoea and dizziness, which, without sufficient fluids, can lead to dehydration. "We recommend drinking plenty of water throughout the day, even when you're not thirsty. If experiencing diarrhoea or vomiting, try using electrolyte drinks, rehydrate quickly and apply sunscreen whenever you are outdoors. This will help those who suffer from heightened sensitivity to UV rays.' Do you need to tell your travel insurance you are taking Mounjaro? Yes. Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' Recommended reading: What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' Insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
The Independent
35 minutes ago
- The Independent
Jeremy Hunt says Lucy Letby's case must be urgently re-examined
Sir Jeremy Hunt is calling for an 'urgent re-examination' of the case of convicted murderer Lucy Letby. It comes just months after the former health secretary apologised to the families of the former nurse's victims at a public inquiry. The Conservative MP pleaded for the Criminal Cases Review Commission (CCRC) to 'speed up their normally painfully slow process'. The CCRC, which investigates potential miscarriages of justice, is considering evidence presented by Letby's legal team from an international panel of medics. They claim that poor medical care and natural causes were to blame for the babies collapsing at the Countess of Chester Hospital's neonatal unit. Letby, 35, is serving 15 whole-life orders after being convicted across two trials at Manchester Crown Court of murdering seven babies and attempting to murder seven others, with two attempts on one of her victims, between June 2015 and June 2016. Giving evidence in January at the Thirlwall Inquiry over Letby's crimes, Sir Jeremy – who was health secretary between 2012 and 2018 – acknowledged the 'appalling crime' took place under his watch. He said he bore ultimate responsibility for the NHS 'insofar as lessons were not learned from previous inquiries that could have been or the right systems were not in place'. Lucy Letby has been convicted of murdering seven babies and attempting to murder seven others (PA Media) He said: 'I want to put on the record my apologies to the families for anything that did not happen that potentially could have prevented such an appalling crime.' Writing in the Daily Mail on Wednesday, Sir Jeremy said: 'I am not arguing that Letby is innocent. That is not my place. I believe in the separation of powers. It must never be the role of any politician to second-guess the outcome of any court decision, let alone a jury trial. 'The pain endured by the families affected must also be at the forefront of our minds. Their suffering is beyond our comprehension and they deserve compassion, respect and ongoing support. 'But most of all, they deserve the truth. And recently, some have begun to cast doubt on what actually happened. Were those tragic deaths caused by an evil woman or were they the result of medical error? 'As someone who has campaigned for more than a decade to reduce avoidable death, that matters to me. 'If Letby really did kill seven babies in their cots and attempted to kill seven more, no punishment short of the death penalty is too harsh. But if they were caused by professional shortcomings, we need to know why. 'More than anything else, we need to make sure other families don't have to go through the same tragedy.' Former health secretary Jeremy Hunt apologised at the Thirlwall Inquiry to families of the victims of Lucy Letby (PA) Sir Jeremy said he had noted the findings of the international panel of paediatric specialists and neonatologists, and had also read a 'wide range of expert concerns about the conduct of the criminal case'. He said: 'Taken together – and it pains me to say it – this analysis raises serious and credible questions about the evidence presented in court, the robustness of expert testimony and the interpretation of statistical data. 'That is why I and parliamentary colleagues such as Sir David Davis, now believe the time has come for these concerns to be addressed as a matter of urgency.' He continued: 'While there is such a high degree of speculation about the potentially unfair prosecution of a healthcare professional, others will feel much more nervous about coming forward about mistakes they may have made. Lessons will not be learned and more babies will die. 'Justice must be done and seen to be done. And that means the CCRC has to speed up their normally painfully slow process.' He added that 'none of this should diminish the compassion we owe the families who have already suffered so much'. He said: 'Re-examination of the evidence is not a denial of their pain. But it will ensure that all of us can have confidence that the truth has been reached through a rigorous and fair process. 'And if medical error was the cause, we can then make sure no more babies die from the same mistakes.' Lucy Letby: Timeline of nurse who murdered seven babies Lawyers for the families of Letby's victims dismissed the medical panel's conclusions as 'full of analytical holes' and 'a rehash' of the defence case heard at trial. The mother of a baby boy who Letby attempted to murder said the families 'already have the truth'. They believe in the British justice system and the jury made the right decision, she said. The mother of another boy, Baby C, who Letby was convicted of murdering, told the Thirlwall Inquiry: 'The media PR campaign aimed to garner public sympathy for Letby demonstrates a complete lack of understanding for Letby's crimes and the complexity of the case. 'The misinformed and inaccurate media circus surrounding this case, our son and the other babies is potentiating the distress of all of the families involved.' Letby, from Hereford, lost two bids in 2024 to challenge her convictions at the Court of Appeal. One was in May, for seven murders and six attempted murders, and one was in October for the attempted murder of a baby girl, which she was convicted of by a different jury at a retrial. Cheshire Constabulary is continuing a review of deaths and non-fatal collapses of babies at the neonatal units of the Countess of Chester and Liverpool Women's Hospital during Letby's time as a nurse from 2012 to 2016. A separate probe by the force into corporate manslaughter and gross negligence manslaughter at the Countess of Chester Hospital also remains ongoing. Lady Justice Thirlwall is due to publish the findings from her public inquiry in early 2026.
The Independent
36 minutes ago
- The Independent
170 patients harmed as a result of cyber attack
Around 170 patients have suffered harm as a result of a cyber attack on blood services at London hospitals and GP surgeries, reports suggest. Pathology services provider Synnovis was the victim of a ransomware attack by a Russian cyber gang in June last year. As a result more than 10,000 appointments were cancelled at the two London NHS trusts that were worst affected. And a significant number of GP practices in London were unable to order blood tests for their patients. Now the Health Service Journal (HSJ) has reported that there were nearly 600 'incidents' linked to the attack, with patient care suffering in 170 of these. This includes one cases of 'severe' harm, 14 which led to 'moderate' harm with the rest identified as 'low harm'. According to NHS guidance severe harm occurs when patients either suffers permanent harm; needs life saving care or could have reduced their life expectancy, among a number of other factors.
